Although there is a large body of knowledge on the increased cardiovascular disease (CVD) risk in rheumatoid arthritis (RA), there is a lack of clinical evidence on management of the increased risk.
CITATION STYLE
Rollefstad, S., Ikdahl, E., & Semb, A. G. (2016). Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis. In Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis (pp. 73–92). Springer International Publishing. https://doi.org/10.1007/978-3-319-26782-1_5
Mendeley helps you to discover research relevant for your work.